| |
|
 |
CorNova Preclinical Results of Valecor Platinum(TM)
Coronary Stent Studies Presented at TCT 2007 Conference (October
23, 2007) – Preclinical Studies
of Valecor Platinum(TM) Coronary Stent System Indicate
Positive Results and Improvements Compared to Market-Leading
Bare Stent.
Click
for Complete Press Release |
|
CorNova (July 11, 2007) –
announced that its wholly-subsidiary, CorNova Latin America Branch Office, has received ANMAT certification (ANMAT # 191/99 - MERCOSUR GMC rule # 4/95), allowing it to market cardiovascular medical devices in South America. CorNova Latin America is managed by Miguel Ferro, Vice-President and General Manager, Latin America. |
|
Private financing completed through the sale of 950,000 shares
(February 6, 2007) – CorNova, Inc., a privately held developer of advanced endovascular devices and catheters, reported that it completed a private financing through the sale of 950,000 shares of Series A Preferred Convertible Stock at $2.50 per share with total gross proceeds of $2,375,000.
Click
for Complete Press Release |
|
CorNova, Inc., has received CE Mark marketing approval for its
ValecorTM Coronary Stent System (December 19, 2006).
– This advanced cobalt-chromium
stent utilizes an innovative design that was developed to maximize
flexibility and conformity while providing uniform expansion
and coverage. The ValecorTM stent has minimal strut thickness
which is believed to play a significant role in reducing restenosis.
Click
for Complete Press Release |
|
Latin American Office
Opened (July 14, 2006) –
CorNova, Inc. announced today that it had established a subsidiary
office, CorNova, Inc, Argentina Branch, to serve as its sales
and distribution center in Latin America for its upcoming
advanced endovascular products. CorNova, Inc, Argentina Branch
is managed by Miguel Ferro, Vice-President and General Manager,
Latin America.
|
|
New Corporate Worldwide
Headquarters Opened (April 5th, 2006) –
CorNova, Inc. announces the opening of its new corporate offices
and laboratories in Burlington, Massachusetts. The state-of-the-art
facilities will serve as the center of CorNova’s domestic
and international administrative and research activities.
|
|
CorNova GmbH
Receives ISO 13485 Certification (January 5th, 2006)
– CorNova, Inc. today announced
that its wholly-subsidiary, CorNova GmbH, has received ISO 13485
certification, allowing it to serve as the official EU manufacturer
of CorNova’s future cardiovascular medical devices. CorNova
GmbH is managed by Kai Baums, Vice-President and General Manager,
Europe.
|
©2008 CorNova, All
Rights Reserved. CorNova is not responsible for any errors or omissions.
Privacy Policy | Trademarks
and Service Marks
Site is maintained by 1-Stop
Design Shop.
Questions? Email the webmaster.
|
